A carregar...
Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma
Leukopenia and selective CD4+ lymphopenia represent major adverse events associated with the use of temozolomide (TMZ), an oral alkylating agent incorporated in the treatment of glioblastoma (GBM). The increased risk of opportunistic infections, including those caused by Pneumocystis jiroveci and cy...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3764971/ https://ncbi.nlm.nih.gov/pubmed/24019780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354429 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|